Recent studies highlight emerging drugs in phase 2/3 and selected phase 1/2 trials for systemic sclerosis treatment. These developments may offer new therapeutic options for patients suffering from this challenging condition.
emerging drugs in phase 2 3 and selected phase 1 2 cellular therapy trials a glimpse into the future of systemic sclerosis treatment
Original title: “Emerging drugs in phase 2/3 and selected phase 1/2 cellular-therapy trials: a glimpse into the future of systemic sclerosis treatment.”